In myeloid leukemias, MYB has been shown to be a critical target of known oncogenes, including HOXA9 and MLL fusions [15, 16], and has been identified as a part of a leukemia stem cell maintenance signature [17]. This evidence concerns the gene MYB and myeloid leukemia.